● Single award · contract
Vir Biotechnology - Ota for Pre-Exposure Prophylactic Monoclonal Antibodies for the Prevention of Influenza…
A single federal award, with both ends of the trail linked.
$65.9M
total award value
2022
action date
27 mo
period
75A50122C00081
PIID
Description
Vir Biotechnology - Ota for Pre-Exposure Prophylactic Monoclonal Antibodies for the Prevention of Influenza Illness and Medical Countermeasures for Other Emerging Pathogens of Pandemic Potential
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceCalifornia →
CategoryNAICS 541714PSC AN11
Competed?Not recorded✓ from source
Total (exact)$65,867,804
More from Department of Health and Human Services
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
awarded 2022$71.7B
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.